YUNNAN BAIYAO GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.33 CNY | 0.00% |
|
-2.43% | +12.57% |
| 04-26 | Yunnan Baiyao Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-24 | Yunnan Baiyao Group Co.,Ltd. Approves Cash Dividend for the Year 2023 | CI |
| Sales 2024 * | 42.27B 5.83B 467B | Sales 2025 * | 45.85B 6.33B 507B | Capitalization | 98.72B 13.62B 1,091B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.59B 634M 50.76B | Net income 2025 * | 5.07B 700M 56.03B | EV / Sales 2024 * | 2 x |
| Net cash position 2024 * | 14.15B 1.95B 156B | Net cash position 2025 * | 16.23B 2.24B 179B | EV / Sales 2025 * | 1.8 x |
| P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
19.6
x | Employees | 8,834 |
| Yield 2024 * |
3.96% | Yield 2025 * |
3.92% | Free-Float | 38.26% |
More Fundamentals
* Assessed data
More news
| 1 week | -2.43% | ||
| Current month | +8.92% | ||
| 1 month | +8.79% | ||
| 3 months | +11.98% | ||
| 6 months | +11.10% | ||
| Current year | +12.57% |
1 week
54.80
57.61
1 month
49.7857.61
Current year
44.8857.61
1 year
44.8859.90
3 years
44.8893.63
5 years
44.88116.63
10 years
33.64116.63
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Dong
CEO | Chief Executive Officer | 47 | 02/03/21 |
Jia Ma
DFI | Director of Finance/CFO | 47 | 31/05/22 |
Pin Yao Yin
COO | Chief Operating Officer | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Shan Xie
BRD | Director/Board Member | 49 | 06/11/22 |
Ying Xia He
BRD | Director/Board Member | 52 | 30/11/89 |
Hong Dong Lu
BRD | Director/Board Member | 58 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.68% | 2 M€ | -16.59% | - | |
| 1.32% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 55.33 | 0.00% | 11,881,920 |
| 25/04/24 | 55.33 | -0.23% | 7,938,530 |
| 24/04/24 | 55.46 | -0.82% | 10,709,100 |
| 23/04/24 | 55.92 | -0.90% | 11,456,260 |
| 22/04/24 | 56.43 | -0.49% | 13,703,900 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory.
China accounts for 98.9% of net sales.
Sector
Pharmaceuticals
Calendar
26/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
55.33
CNY
Average target price
62.1
CNY
Spread / Average Target
+12.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.57% | 13.62B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 000538 Stock
